Barinthus Biotherapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Barinthus Biotherapeutics's balance sheet done over the years? Its assets were worth $214,506,000 last year, which is less than in the previous period. 13% of Barinthus Biotherapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $27,511,000, which means an increase by 2% compared compared to last year.

Debt to Assets

Barinthus Biotherapeutics plc (NASDAQ:BRNS): Debt to assets
2019 19043240 41.12M 215.94%
2020 50666000 87.57M 172.85%
2021 280715000 28.15M 10.03%
2022 270205000 27.00M 9.99%
2023 214506000 27.51M 12.83%

BRNS Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
142.09M194.38M214.05M43.26M11.43M
Short term investments
00000
Net receivables
7.93M18.09M11.71M4.60M3.90M
Inventory
00000
Other current assets
6.87M563K995K29K909.22K
Total current assets
156.90M213.04M226.76M47.90M16.24M
Non-current assets:
Property, Plant and Equipment
19.40M15.71M9.08M2.76M2.79M
Goodwill
12.20M12.20M12.63M00
Intangible assets
25.10M28.26M31.43M00
Long term investments
0-8.93M-4.00M00
Other non-current assets
882K976K804K00
Total non-current assets
57.60M57.16M53.95M2.76M2.79M
Total assets
214.50M270.20M280.71M50.66M19.04M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
00182K245K269.91K
Short term debt
3.57M433K682K192K171.97K
Total current liabilities
12.59M12.24M11.15M7.64M5.75M
Non-current liabilities:
Long term debt
11.19M8.34M6.54M46.17M1.60M
Deferred tax
00000
Other non-current liabilities
3.14M2.67M2.37M33.76M33.76M
Total non-current liabilities
14.91M14.76M16.99M79.93M35.37M
Total liabilities
27.51M27.00M28.15M87.57M41.12M
Data source